Teckro, the indigenous Irish firm transforming clinical trials for leading pharmaceutical and emerging biotech companies today officially announced 45 high-end tech jobs for Dublin, representing more than 100% growth in staff here.
The company currently has more than 110 employees with offices in Limerick and the US, but the majority of the new roles will be in the company’s Engineering Excellence Hub in Dublin’s Silicon Docks. The technical jobs will span functions across engineering, data science, design and usability, quality and product management.
The staff expansion follows the recent appointments of Anita Callan as Vice President of Product, most recently from Aer Lingus, and Neil Flanagan as Vice President of Engineering, previously with Munich Re to Teckro’s leadership team.
Speaking at the announcement CEO and Co-Founder Gary Hughes said, “Although technology has revolutionized so many industries, the experience of participating in a clinical trial if you are a doctor, research nurse or patient has not changed in the last two decades. The industry still heavily relies on paper and inefficient processes. At Teckro, we are on a mission to simplify the process and make clinical trials more accessible for everyone involved. We are looking for more talented people, especially in technical roles, to join us and make an impact.”
The company, founded in 2015 by brothers Gary and Nigel Hughes and CTO Jacek Skrzypiec, is currently in scale out mode. This is the second startup founded in Ireland by the Hughes brothers and Skrzypiec, whose previous business, Firecrest Clinical, was sold to Nasdaq-listed clinical research giant ICON in 2011.
Teckro provides solutions to simplify and modernize clinical research for leading pharmaceutical and biotech companies, currently managing more than 100 clinical trials and actively used by more than 11,800 study sites worldwide. Earlier this year the company announced a Series C funding round from major US venture capital firms, including Founders Fund, Bill Maris’ Section 32, Borealis Ventures, Northpond Ventures and Sands Capital Ventures that brought its total funding to $43 million and making it one of the fastest growing venture-backed companies developing product in Ireland.
Minister for Business, Enterprise and Innovation Heather Humphreys welcomed the jobs saying, “It’s great to see an Irish company based in Dublin and Limerick succeed and grow internationally, especially one with a mission that will ultimately benefit patients and healthcare professionals in research to address global health problems. These 45 new tech jobs will play an important role for Teckro to deliver solutions from Ireland that will improve the clinical trial process throughout the world. This is another great example of how our SMEs are investing in new technologies, which is an important element in our Future Jobs Ireland strategy.”
Teckro clinical trial software transforms the study protocol into actionable data for everyone – research staff, CROs and sponsors. Global pharmaceuticals and emerging biotechs alike digitize their clinical trials with Teckro. Headquartered in Ireland, Teckro has locations across Europe and the United States. Visit www.teckro.com for more information.